U.S. markets open in 9 hours 17 minutes

Revive Therapeutics Ltd. (RVV.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.3800-0.0050 (-1.30%)
At close: 3:59PM EST
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in CAD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 3/6/2021
Current
12/31/20209/30/20206/30/20203/31/202012/31/2019
Market Cap (intraday) 5
98.50M146.81M63.93M57.97M17.21M4.34M
Enterprise Value 3
94.56M143.75M63.81M57.85M17.62M4.55M
Trailing P/E
N/AN/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
N/AN/AN/AN/AN/AN/A
Price/Book (mrq)
9.9915.6710.599.6035.496.59
Enterprise Value/Revenue 3
N/AN/AN/AN/AN/AN/A
Enterprise Value/EBITDA 6
-8.15-58.53-15.95-18.31-11.81-13.78

Premium access required.

Learn more

Trading Information

Stock Price History

Beta (5Y Monthly) -0.16
52-Week Change 3442.86%
S&P500 52-Week Change 339.88%
52 Week High 30.9200
52 Week Low 30.0000
50-Day Moving Average 30.5510
200-Day Moving Average 30.4001

Share Statistics

Avg Vol (3 month) 33.4M
Avg Vol (10 day) 32.07M
Shares Outstanding 5236.79M
Float 251.82M
% Held by Insiders 19.56%
% Held by Institutions 10.12%
Shares Short (Feb 11, 2021) 46.77M
Short Ratio (Feb 11, 2021) 42.67
Short % of Float (Feb 11, 2021) 4N/A
Short % of Shares Outstanding (Feb 11, 2021) 42.86%
Shares Short (prior month Jan 14, 2021) 4557.62k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun 29, 2020
Most Recent Quarter (mrq)Dec 30, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-106.50%
Return on Equity (ttm)-226.22%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -10.25M
Net Income Avi to Common (ttm)-11.7M
Diluted EPS (ttm)-0.0630
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)4.38M
Total Cash Per Share (mrq)0.02
Total Debt (mrq)432.58k
Total Debt/Equity (mrq)4.39
Current Ratio (mrq)10.42
Book Value Per Share (mrq)0.04

Cash Flow Statement

Operating Cash Flow (ttm)-4.3M
Levered Free Cash Flow (ttm)-1.94M